Vericheck ddPCR Replication Competent ™ Lentivirus Kit
Source: Bio-Rad Laboratories, Inc.
A Faster, Quantitative, and Orthogonal Method for Testing RCL
The US FDA recommends testing for replication-competent lentivirus (RCL) in cell and gene therapy production due to potential health risks. Current testing methods are slow and inefficient, taking 30-45 days for results. Bio-Rad's Vericheck ddPCR RCL Kit provides a faster, cost-effective, and specific solution for lentivirus testing. This fully validated kit presents a more efficient alternative for RCL testing.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Bio-Rad Laboratories, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more